English
简体中文
Total: £ 56.28
2026-03-30 | Pages: 116 | Tables: 117
The global Endocrinology and Metabolism market was valued at US$ 105550 million in 2025 and is anticipated to reach US$ 219550 million by 2032, at a CAGR of 11.2% from 2026 to 2032.Endocrinology is the internal medicine subspecialty dedicated to the ...
2026-03-30 | Pages: 107 | Tables: 106
The global Natural Killer Cell Therapeutics market was valued at US$ 254 million in 2025 and is anticipated to reach US$ 2489 million by 2032, at a CAGR of 39.1% from 2026 to 2032.NK cells, a type of immune cell, have received a lot of attention for ...
2026-03-30 | Pages: 155 | Tables: 145
The global Hepatitis Delta Virus (HDV) Infection market was valued at US$ 2058 million in 2025 and is anticipated to reach US$ 12630 million by 2032, at a CAGR of 30.0% from 2026 to 2032.Hepatitis D, also known as delta hepatitis, is a liver infectio...
2026-03-30 | Pages: 110 | Tables: 116
The global 7-Aminocephalosporanic Acid (7-ACA) market was valued at US$ 802 million in 2025 and is anticipated to reach US$ 1237 million by 2032, at a CAGR of 6.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-03-27 | Pages: 108 | Tables: 104
The global Scaffold Free 3D Stem Cell Culture market was valued at US$ 34.35 million in 2025 and is anticipated to reach US$ 86.41 million by 2032, at a CAGR of 14.3% from 2026 to 2032.Scaffold-free 3D stem cell culture is a technique used to grow st...
2026-03-27 | Pages: 105 | Tables: 103
The global Ocular Gene Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Ocular Gene Therapy is projected to increase from US$ million in 20...
2026-03-27 | Pages: 114 | Tables: 115
The global Pet Tick Repellent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Tick and flea prevention involves various measures aimed at protecting pets from infestations and ...
2026-03-27 | Pages: 119 | Tables: 118
The global Pet Tick and Flea Repellent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Tick and flea prevention involves various measures aimed at protecting pets from infestat...
2026-03-27 | Pages: 113 | Tables: 117
The global Tick and Flea Repellent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Tick and flea prevention involves various measures aimed at protecting pets from infestations...
2026-03-27 | Pages: 111 | Tables: 118
The global Tick and Flea Prevention market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Tick and flea prevention involves various measures aimed at protecting pets from infestation...
2026-03-27 | Pages: 109 | Tables: 101
The global Oral Chronic Disease Management Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Oral chronic disease management services refer to a series of prevention, tre...
2026-03-27 | Pages: 101 | Tables: 103
The global Solid Organ Transplantation Rejection (SOT) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Solid Organ Transplantation Rejection (SOT)...
2026-03-27 | Pages: 106 | Tables: 101
The global S7 Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.S7 nuclease is an endonuclease enzyme derived from the bacterium Bacillus stearothermophilus, which is ch...
2026-03-27 | Pages: 103 | Tables: 108
The global Staphylococcal Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Staphylococcal nuclease is an endonuclease enzyme derived from Staphylococcus aureus. It cata...
2026-03-27 | Pages: 105 | Tables: 102
The global Micrococcal Nuclease market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Micrococcal nuclease (MNase) is an endonuclease enzyme derived from the bacterium Micrococcus lu...
